First-in-human study of the injection JY1001 in healthy adults
Part of Pain clinical trials.
This early-phase study tests a new injectable drug (JY1001) in healthy volunteers to see how safe it is and how the body handles it. It's a first step in finding out if the drug could help people with certain conditions in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult (18 years or older).
- Men should weigh at least 50 kg (about 110 lbs); women at least 45 kg (about 99 lbs).
- Your body mass index (BMI) should be between 19 and 28.
- You should not have any medical conditions that could make the study risky for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection for the first time in healthy volunteers to see how safe it is and how the body handles it. It may help determine if the drug is suitable for future patients.
This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.
This early-stage trial tests a new medicine called JMT206 in healthy people to see if it is safe and how the body handles it. Healthy volunteers, ages 18 to 60, are needed to help researchers learn about the drug's effects and how it moves through the body.
This is a first-in-human study of a new injected medication that may help with certain conditions. The trial is looking for healthy volunteers to check the drug's safety and how it works in the body.
This study tests a new injection (JYB1904) that may help control allergic reactions. It is for teenagers aged 12 to 17 who have had allergic conditions, to see if the drug is safe and how it works in this age group.
This study tests a new medicine called KR25102 to see if it is safe and how the body handles it. It may help develop a treatment for pain.
Hear when a new Pain After Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.